Current status of treatment for primary effusion lymphoma.
about
Co-infections and Pathogenesis of KSHV-Associated MalignanciesHuman Herpesvirus Type 8-associated Large B-cell Lymphoma: A Nonserous Extracavitary Variant of Primary Effusion Lymphoma in an HIV-infected Man: A Case Report and Review of the Literature.Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.Human Herpesvirus 8-Unrelated Primary Effusion Lymphoma-Like Lymphoma in an Elderly Korean Patient with a Good Response to Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone.A role for MALT1 activity in Kaposi's sarcoma-associated herpes virus latency and growth of primary effusion lymphoma.Primary effusion lymphoma in the absence of HIV infection--clinical presentation and management.STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies.Diagnosis and Management of a Pancreaticopleural Fistula in a Patient with AIDS and a Large Pleural Effusion.Primary Effusion Lymphoma: Is Dose-Adjusted-EPOCH Worthwhile Therapy?Multi-targeted therapy of everolimus in Kaposi's sarcoma associated herpes virus infected primary effusion lymphoma.Restoring PU.1 induces apoptosis and modulates viral transactivation via interferon-stimulated genes in primary effusion lymphoma.Primary Effusion Lymphoma (PEL)-Like Lymphoma in a Child With Congenital Immunodeficiency.Inhibition of autophagy by chloroquine induces apoptosis in primary effusion lymphoma in vitro and in vivo through induction of endoplasmic reticulum stress.Head and Neck Lymphomas in HIV Patients: a Clinical Perspective.Clinical characteristics and survival outcome of primary effusion lymphoma: A review of 105 patients.Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death.The promising role of monoclonal antibodies for immunotherapy of the HIV-associated cancer, non-Hodgkin lymphoma.Viral Oncology: Molecular Biology and Pathogenesis.Case report of a primary effusion lymphoma successfully treated with oral valganciclovir after failing chemotherapy.A unique case of primary effusion lymphoma-like lymphoma showing disappearance and recurrence of the body cavity effusion.Inhibition of Tip60 Reduces Lytic and Latent Gene Expression of Kaposi's Sarcoma-Associated Herpes Virus (KSHV) and Proliferation of KSHV-Infected Tumor Cells.Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.Primary Effusion Lymphoma without an Effusion: A Rare Case of Solid Extracavitary Variant of Primary Effusion Lymphoma in an HIV-Positive Patient.Epstein–Barr Virus-Induced Metabolic Rearrangements in Human B-Cell Lymphomas.Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma
P2860
Q26766493-8A184AE6-4855-48D3-805A-5BBF7DFD66D7Q33647573-45AF5039-7628-4B81-B471-D9445A90DD87Q35861265-411AACCB-4AE0-445C-BBED-81508BA1B820Q37606690-C74D56BF-8EC0-4E9F-90D7-443512CDD8CCQ37683385-A972FFD9-712A-45D3-82A8-3BE1E16F19B8Q38270091-F014F67B-06D3-4FDE-9259-71DC72082B7FQ38838049-DA9187EA-CE53-42E7-BCBC-C450DD23156AQ38909416-158E7895-D5D1-42DF-BAF2-E419E5F430B0Q38961392-9DE5B3DC-1A77-4029-BB5B-FFAB2A35BAC9Q39555886-9C928D32-87E7-4697-A23C-3DE624F97710Q40144368-4657C354-373C-4742-91D1-38FD1BFAFB84Q40210866-0FBD3063-9C6A-4F88-8C63-D2C65CC3A5EEQ40671903-DA64586E-A632-4C6B-B2C1-CEA24DDAE556Q41914515-EC923169-8DF4-446E-934E-FBA14EE588DEQ41919568-4FA1A62F-9DF5-4483-9A72-36CD472C7A94Q44551214-400A42E3-850F-4C8F-BF81-8398A34D05F7Q47105497-B72B9BF6-F1EF-4E2F-9691-D7381A866938Q47563526-48B966A1-70EF-4D0B-A540-D4418F73121DQ47571734-B8628ADB-F00D-4819-8D92-174489074A7AQ48330061-462D4155-07EE-461C-93E4-108B05A9FDBDQ52739020-CD50E37F-49EB-4114-B3C4-6E5E5EAB3D52Q54217632-A3A8B3B0-D85D-4BD6-9FF3-A4EFEC5795F1Q54217772-317D2913-5550-4B01-B3AC-FE627F6EB780Q54241657-461EC575-765A-4C08-8F0C-8163EE9F1433Q55272984-3C5C6CF4-D343-49F8-89E8-4511EF6BD3C6Q58778363-B59CB466-2047-4E21-87C9-09F534365C8E
P2860
Current status of treatment for primary effusion lymphoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Current status of treatment for primary effusion lymphoma.
@en
type
label
Current status of treatment for primary effusion lymphoma.
@en
prefLabel
Current status of treatment for primary effusion lymphoma.
@en
P2093
P2860
P356
P1476
Current status of treatment for primary effusion lymphoma.
@en
P2093
Hiroki Goto
Mihoko Yotsumoto
Seiji Okada
P2860
P356
10.5582/IRDR.2014.01010
P577
2014-08-01T00:00:00Z